28 CFR §79.22
Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
To establish eligibility for compensation under this subpart, a claimant or eligible surviving beneficiary must establish each of the following:
- (a)
- (1)That the claimant was physically present at any place within the affected area for a period of at least two years (24 consecutive or cumulative months) during the period beginning on January 21, 1951, and ending on October 31, 1958; or
- (2)That the claimant was physically present at any place within the affected area for the entire, continuous period beginning on June 30, 1962, and ending on July 31, 1962; and
- (b)That after such period of physical presence the claimant contracted one of the following specified compensable diseases:
- (1)Leukemia (other than chronic lymphocytic leukemia), provided that:
- (2)Multiple myeloma, provided onset occurred at least five years after first exposure;
- (3)Lymphomas, other than Hodgkin's disease, provided onset occurred at least five years after first exposure;
- (4)Primary cancer of the thyroid, provided onset occurred at least five years after first exposure;
- (5)Primary cancer of the male or female breast, provided onset occurred at least five years after first exposure;
- (6)Primary cancer of the esophagus, provided onset occurred at least five years after first exposure;
- (7)Primary cancer of the stomach, provided onset occurred at least five years after first exposure;
- (8)Primary cancer of the pharynx, provided onset occurred at least five years after first exposure;
- (9)Primary cancer of the small intestine, provided onset occurred at least five years after first exposure;
- (10)Primary cancer of the pancreas, provided onset occurred at least five years after first exposure;
- (11)Primary cancer of the bile ducts, provided onset occurred at least five years after first exposure;
- (12)Primary cancer of the gallbladder, provided onset occurred at least five years after first exposure;
- (13)Primary cancer of the salivary gland, provided onset occurred at least five years after first exposure;
- (14)Primary cancer of the urinary bladder, provided onset occurred at least five years after first exposure;
- (15)Primary cancer of the brain, provided onset occurred at least five years after first exposure;
- (16)Primary cancer of the colon, provided onset occurred at least five years after first exposure;
- (17)Primary cancer of the ovary, provided onset occurred at least five years after first exposure;
- (18)Primary cancer of the liver, provided,
- (19)Primary cancer of the lung, provided onset occurred at least five years after first exposure.